Literatur
Dralle H, Musholt TJ, Schabram J et al (2013) German association of endocrine surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg 398:347–375
Goffredo P, Cheung K, Roman SA, Sosa JA (2013) Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1,200 patients. Ann Surg Oncol 20:767–772
International Agency for Research on Cancer (2017) Tumours of the thyroid gland. In: Lloyd R, Osamura RY, Klöppel G, Rosai J (Hrsg) WHO classification of tumours of endocrine organs, 4. Aufl. IARC, Lyon, S 65–143
Nikiforov YE, Seethala RR, Tallini G et al (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2:1023–1029
Robinson A, Schneider D, Sippel R, Chen H (2017) Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion? J Surg Res 207:235–240
Rosai J, DeLellis RA, Carcangiu ML, Frable WJ, Tallini G (2014) Tumors of the thyroid and parathyroid glands. In: AFIP atlas of tumor pathology. 4th series, fascicle 21. American Registry of Pathology, Silver Spring, S 543–560
Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS (2001) A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 91:505–524
van Heerden JA, Hay ID, Goellner JR et al (1992) Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 112:1130–1138
Volante M, Collini P, Nikiforov YE et al (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256–1264
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Schad gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
The supplement containing this article is not sponsored by industry.
Rights and permissions
About this article
Cite this article
Schad, A. Subtypisierung des follikulären Schilddrüsenkarzinoms (WHO 2017). Pathologe 40 (Suppl 3), 360–362 (2019). https://doi.org/10.1007/s00292-019-00707-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-019-00707-5